Lake Mary, FL3 Active Studies

Advanced Solid Tumors Clinical Trials in Lake Mary, FL

Find 3 actively recruiting advanced solid tumors clinical trials in Lake Mary, FL. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,172
Enrolling

Recruiting Advanced Solid Tumors Studies in Lake Mary

About Advanced Solid Tumors Clinical Trials in Lake Mary

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 3 advanced solid tumors clinical trials recruiting participants in Lake Mary, FL. These studies are seeking a combined 1,172 participants. Research is being sponsored by Eli Lilly and Company, Servier Bio-Innovation LLC, Jacobio Pharmaceuticals Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Lake Mary — FAQ

Are there advanced solid tumors clinical trials in Lake Mary?

Yes, there are 3 advanced solid tumors clinical trials currently recruiting in Lake Mary, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lake Mary?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lake Mary research site will contact you about next steps.

Are clinical trials in Lake Mary free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lake Mary studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 3 active trials in Lake Mary are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov